Ever Supreme Bio Technology Co. Ltd (6712.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan
Ever Supreme Bio Technology Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 933.81 m TWD | 1.02 bn TWD |
| Gross profit | 660.04 m TWD | 721.33 m TWD |
| Operating income | 465.64 m TWD | 438.94 m TWD |
| EBIT | 460.87 m TWD | 525.25 m TWD |
| Net income | 367.25 m TWD | 429.43 m TWD |
| Diluted EPS – continuing operations | 4.14 TWD | 4.90 TWD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ever Supreme Bio Technology Co. Ltd
Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan. The company operates through two segments: Cell Preparation Business and Other Operating Business segments. The company's products include umbilical cord mesenchymal stem cells, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke. It also develops dendritic cell vaccine, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; chimeric antigen receptor immune cells, a chimeric antigen receptor immune cells product; and allogeneic bone-marrow stem cells, used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. In addition, the company develops allogeneic umbilical cord mesenchymal stem cells (UMSC01), used to treat cardiovascular diseases and strokes. Further, it engages in the sale of other health products and related businesses; and cell preparations and investment activities in biotechnology and medical industry businesses. Ever Supreme Bio Technology Co., Ltd was incorporated in 2016 and is based in Taichung, Taiwan.
More stocks
- Voneseals Technology (Shanghai) Inc. A (301161.SZ)
- Troilus Mining Corp (TLG.TO)
- Ellaktor SA (ELLAKTOR.AT)
- Guangzhou Amsky Technology Co Ltd (300521.SZ)
- Bank of Marin Bancorp (BMRC)
- Eson Precision Ind Co Ltd (5243.TW)
- Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811.SS)
- Ways Electron Co Ltd (605218.SS)
- RELMADA THERAPEUTICS, INC. (RLMD)
- FuJian YanJing HuiQuan Brewery Co Ltd (600573.SS)
- ATN International, Inc. (ATNI)
- ZRP Printing Group Co. Ltd. (301223.SZ)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.